Centogene and lifera, a public investment fund (pif) company, complete strategic joint venture transaction

Cambridge, mass. and rostock, germany and berlin, nov. 28, 2023 (globe newswire) -- centogene n.v. (nasdaq: cntg), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it has completed the transaction to form a new joint venture (jv) with lifera, a biopharmaceutical company wholly-owned by the public investment fund (pif). the jv has been formed to increase local and regional access as well as rapid delivery of world-class genomic and multiomic testing to patients in saudi arabia and countries of the gulf cooperation council (gcc). the new jv will be located in riyadh, saudi arabia, and operate under the name ‘lifera omics'.
CNTG Ratings Summary
CNTG Quant Ranking